The Daily Telegraph came out with the news, relying on the sources, suggesting that UK Prime Minister (PM) Boris Johnson’s US visit aims to convince US President Joe Biden over the travel ban.
“The Prime Minister will make an ‘impassioned’ case for why Mr. Biden should lift his travel ban by allowing fully vaccinated people in the UK to travel directly into American,” adds The Daily Telegraph.
The news also highlights UK Johnson’s push for a promise of billions of dollars more climate financing for developing nations to help Mr. Johnson to hit a flagship Cop26 UN climate conference target. It’s mentioned in the piece, “Currently, it is estimated that between $80 billion and $90 billion a year has been pledged.”
Markets are more interested in hearing the details of how the US and the UK, coupled with Australia and Japan, will battle China (indirectly) after the AUKUS pact. Hence, the reaction to the news was negligible by the press time. Also, the bank holidays in Japan and China dims the importance of any data/events.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.